SMALL CAP SIREN

Delisting tracker · as of Nov 2, 2026

Moleculin Biotech, Inc. ($MBRX): exchange listing notices

Nasdaq · Delisting determination (no compliance period) · minimum bid price, low share price (≤$0.10) / reverse-split limits

No deadline stated in the latest filing.
Panel / hearing: appeal pending

From the company's 8-K Item 3.01 filings on SEC EDGAR (CIK 1659617). Read each filing before relying on it; our parsing can be wrong. All companies on the tracker → · JSON: /api/v1/tracker?ticker=MBRX

Item 3.01 filings, newest first

1. Sep 18, 2026: Delisting determination (no compliance period)

   Nasdaq delisting determination (minimum bid price) (no compliance period available); hearings panel appeal pending.

   Notice date Sep 15, 2026 · No deadline stated

   Read the 8-K on sec.gov →